EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical-radiomics nomogram using contrast-enhanced CT to predict histological grade and survival in pancreatic ductal adenocarcinoma

Chunyuan Cen, Chunyou Wang, Siqi Wang, Kan Wen, Liying Liu, Xin Li, Linxia Wu, Mengting Huang, Ling Ma, Huan Liu, Heshui Wu, Ping Han

Frontiers in Oncology · 04.09.2023 · 13

DOI: 10.3389/fonc.2023.1218128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 04.09.2023. Verfasst von Chunyuan Cen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Tumor grading is important for prognosis of pancreatic ductal adenocarcinoma (PDAC). In this study, we developed preoperative clinical-radiomics nomograms using features from contrast-enhanced CT (CECT), to discriminate high-grade and low-grade PDAC and predict overall survival (OS).

Methods

In this single-center, retrospective study conducted from February 2014 to April 2021, consecutive PDAC patients who underwent CECT and had pathologically identified grading were randomized to training (n=200) and test (n=84) cohorts for development of model to predict histological grade based on radiomics scores from CECT (HGrad). Another 42 patients were used as external validation cohort of HGrad. A nomogram (HGnom) was constructed using radiomics score, CA12-5 and smoking to predict histological grade. A second nomogram (Pnom) was constructed using radiomics score, CA12-5, TNM, adjuvant treatment, resection margin and microvascular invasion to predict OS in radical resection patients (217 of 284).

Results

Among 326 patients, 122 were high-grade (120 poorly differentiated and 2 undifferentiated). The HGrad yielded AUCs of 0.75 (95% CI: 0.64, 0.85) and 0.76 (95% CI: 0.60, 0.91) in test and validation cohorts. The HGnom achieved AUCs of 0.77 (95% CI: 0.66, 0.87), and the predicted grades calibrated well with actual grades ( P =.13). OS was different between the grades predicted by radiomics scores ( P =.01). The integrated AUC of the Pnom for predicting OS was 0.80 (95% CI: 0.75, 0.88).

Conclusion

Compared with the HGrad using features from CECT, the HGnom demonstrated higher performance for predicting histological grade. The Pnom helped identify patients with high survival outcome in pancreatic ductal adenocarcinoma.

Schlagwörter

Stichwörter der Autor:innen

histological gradeoverall survivalpancreatic ductal adenocarcinomaradiomicsx-ray computed tomography

Autor:innen und Institutionen

  • Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Hubei Province Key Laboratory of Molecular Imaging, Wuhan, Hubei, China.
  • Department of Pancreatic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Department of Radiology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • He Kang Corporate Management (SH) Co. Ltd, Shanghai, China.
  • Advanced Application Team, GE Healthcare, Shanghai, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Cen, C., Wang, C., Wang, S., Wen, K., Liu, L., Li, X., Wu, L., Huang, M., Ma, L., Liu, H., Wu, H., & Han, P. (2023). Clinical-radiomics nomogram using contrast-enhanced CT to predict histological grade and survival in pancreatic ductal adenocarcinoma. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1218128

Vancouver

Cen C, Wang C, Wang S, Wen K, Liu L, Li X, et al. Clinical-radiomics nomogram using contrast-enhanced CT to predict histological grade and survival in pancreatic ductal adenocarcinoma. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.1218128

BibTeX
@article{Cen2023,
  author = {Cen, Chunyuan and Wang, Chunyou and Wang, Siqi and Wen, Kan and Liu, Liying and Li, Xin and Wu, Linxia and Huang, Mengting and Ma, Ling and Liu, Huan and Wu, Heshui and Han, Ping},
  title = {Clinical-radiomics nomogram using contrast-enhanced CT to predict histological grade and survival in pancreatic ductal adenocarcinoma},
  journal = {Frontiers in Oncology},
  year = {2023},
  volume = {13},
  doi = {10.3389/fonc.2023.1218128}
}
Kostenlos starten →